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Comparison of T2-Weighted Edema Imaging With the MR-Assessed Endocardial
Surface Area and Validation Against Angiographic Scoring
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Josefine Meissner, BSC,* Suzanne de Waha, MD,* Philipp Lurz, MD,*
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O B J E C T I V E S The objective of this study was to assess the area at risk (AAR) in ST-segment
elevation myocardial infarction with 2 different cardiac magnetic resonance (CMR) imaging methods and
to compare them with the validated angiographic Alberta Provincial Project for Outcome Assessment in
Coronary Heart Disease Score (APPROACH-score) in a large consecutive patient cohort.
B A C KG ROUND Edema imaging with T2-weighted CMR and the endocardial surface area (ESA)
assessed by late gadolinium enhancement have been introduced as relatively new methods for AAR
assessment in ST-segment elevation myocardial infarction. However, data on the utility and validation
of these techniques are limited.
METHOD S A total of 197 patients undergoing primary percutaneous coronary intervention in acute
ST-segment elevation myocardial infarction were included. AAR (assessed with T2-weighted edema
imaging and the ESA method), infarct size, and myocardial salvage (AAR minus infarct size) were
determined by CMR 2 to 4 days after primary angioplasty. Angiographic AAR scoring was performed by
use of the APPROACH-score. All measurements were done ofﬂine by blinded observers.
R E S U L T S The AAR assessed by T2-weighted imaging showed good correlation with the angiographic
AAR (r  0.87; p  0.001), whereas the ESA showed only a moderate correlation either to T2-weighted
imaging (r 0.56; p 0.001) or the APPROACH-score (r 0.44; p 0.001). Mean AAR by ESA (20.0 11.7%
of left ventricular mass) was signiﬁcantly (p 0.001) smaller than the AAR assessed by T2-weighted imaging
(35.6  10.9% of left ventricular mass) or the APPROACH-score (27.9  10.5% of left ventricular mass) and
showed a signiﬁcant negative dependence on myocardial salvage index. In contrast, no dependence of
T2-weighted edema imaging or the APPROACH-score on myocardial salvage index was seen.
CONC L U S I O N S The AAR can be reliably assessed by T2-weighted CMR, whereas assessment of the
AAR by ESA seems to be dependent on the degree of myocardial salvage, thereby underestimating the
AAR in patients with high myocardial salvage such as aborted infarction. Thus, assessment of the AAR
with the ESA method cannot be recommended. (Myocardial Salvage and Contrast Dye Induced
Nephropathy Reduction by N-Acetylcystein [LIPSIA-N-ACC]; NCT00463749) (J Am Coll Cardiol Img
2011;4:967–76) © 2011 by the American College of Cardiology Foundation
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968cute occlusion of a coronary artery leads to a
process of myocyte necrosis, which spreads
from the subendocardium of the perfusion
bed to the subepicardial layers, the so-
called wave front phenomenon (1). Without reper-
fusion or relevant collaterals, this process ends in
complete necrosis of the cardiomyocytes within the
perfusion bed. Early reopening of the infarct-
related artery can interrupt this process and lead to
tissue salvage within the area at risk (AAR), albeit
reperfusion itself might induce myocyte damaging
processes known as reperfusion injury (2). In gen-
eral, the resulting necrotic zone in reperfused acute
myocardial infarction (AMI) is significantly smaller
than the AAR before reperfusion. With angio-
graphic jeopardy scores such as the Alberta Provin-
cial Project for Outcome Assessment in Coronary
Heart Disease Score (APPROACH-
score) the AAR can be calculated (3).
However, for direct measurement of the
myocardial AAR, few techniques have
been developed. In recent studies (4,5),
AAR has often been measured by single-
photon emission computed tomography
(SPECT), which has limitations because
of availability and handling in AMI. Two
newer technologies for AAR assessment
in AMI using cardiac magnetic resonance
(CMR) have been recently introduced (6–
8). The most widely used method for
assessment of the AAR is T2-weighted
CMR. After initial validation in animals
(6,9), the ability of this method to detect
myocardial edema and, thereby, the AAR
after ischemia has been demonstrated in
humans (7,10,11). Furthermore, it has
een demonstrated that edema can be seen as early
s 30 min after ischemia onset (12), seems to be
table over 1 week (13), and can be assessed with
ood reproducibility between days 2 and 3 (14).
oreover, the amount of myocardial salvage as
efined by this approach also predicts patient out-
ome (15).
Another method for estimating the AAR is the
ndocardial surface area (ESA) method, which is
easured on contrast-enhanced magnetic reso-
ance images. The ESA uses the hypotheses that
ecrosis first spreads to a final subendocardial extent
nd then only improves in transmurality according
o the wave front phenomenon (8). The AAR is
alculated by the relation of endocardial extent of
ate gadolinium enhancement (LGE) to the total
rea
dex
ssion
ionndocardial circumference. CThe ESA method has been applied in several
rials (8,10,16). However, a comparison of T2-
weighted imaging versus the ESA method in a large
consecutive patient cohort with ST-segment eleva-
tion myocardial infarction (STEMI) is lacking
(10,13,16,17).
Therefore, the aim of the current trial was to
study and compare the performance of T2-weighted
maging versus ESA for assessment of the AAR and
o validate these two CMR approaches against the
ngiographic APPROACH-score.
METHODS
This prospective trial is a subanalysis of the
LIPSIA-N-ACC (Myocardial Salvage and Con-
trast Dye Induced Nephropathy Reduction by
N-Acetylcystein) trial, which compared high-
dose N-acetylcysteine versus placebo for reperfu-
sion injury prevention in STEMI patients and
did not show a difference between the treatment
groups. The detailed design and main results of
the trial have been previously published (18). In
brief, between November 2006 and February
2008, 251 consecutive patients were enrolled and
underwent primary percutaneous coronary inter-
vention for STEMI (Fig. 1). Patients were eligi-
ble, if symptoms lasted 12 h and if ST-segment
elevation of 0.1 mV in 2 extremity leads or
0.2 mV in 2 precordial leads was present. The
study had been approved by the local ethics
committee and all patients gave written informed
consent.
Primary percutaneous coronary intervention. Primary
ngioplasty was performed as described previ-
usly (18). In brief, the use of bare-metal or
rug-eluting stents was left to the discretion of
he interventional cardiologist. Additional use of
hrombectomy was recommended depending on
elevant thrombus. All patients were treated with
spirin, heparin, and clopidogrel. The use of
lycoprotein IIb/IIIa inhibitors, angiotensin-
onverting enzyme inhibitors, beta-blockers, and
tatins was strongly recommended.
Angiographic analysis. Angiographic AAR assess-
ent was performed offline by 2 blinded observers
sing the modified APPROACH-score as de-
cribed previously (8). This system is based on a
core, which divides the left ventricle (LV) into
egions according to pathological studies in hu-
ans evaluating the relative proportion of myo-
ardium perfused by each coronary artery (19,20).A B B R E V I A T I O N S
A N D A C R O N YM S
AAR area at risk
AMI acute myocardial
infarction
CMR cardiac magnetic
resonance
ESA endocardial surface a
IQR interquartile range
LGE late gadolinium
enhancement
LV left ventricle
MSImyocardial salvage in
SPECT single-photon emi
computed tomography
STEMI ST-segment elevatonsidering the location (proximal, mid, or dis-
u
S
p
s
m
w
s
n
(
w
w
r
C
s
d
m
I
p
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 9 , 2 0 1 1
S E P T E M B E R 2 0 1 1 : 9 6 7 – 7 6
Fuernau et al.
Area at Risk by Magnetic Resonance
969tal) of the culprit lesion, vessel dominance, site of
occlusion, and size of major branches of the
infarcted artery, the score calculates the jeopar-
dized myocardium for a given site of occlusion
(Table 1, Fig. 2A) (3,8).
Cardiac magnetic resonance. CMR was performed
sing a 1.5-T scanner (Intera CV, Philips Medical
ystems, Best, the Netherlands). The detailed scan
rotocol and sequence parameters have been de-
cribed previously (18). In brief, visualization of
yocardial edema was performed using a T2-
eighted triple inversion recovery breath-hold pulse
equence (Figs. 2B and 3A) (6,7,21). Early and
LGE images covering the whole ventricle were
acquired 1 and 15 min after intravenous adminis-
tration of gadolinium-chelate (Gadovist, Bayer
Schering Pharma, Berlin, Germany) with an inver-
sion recovery gradient echo sequence. Inversion
times were individually adjusted to optimize nulling
of apparently normal myocardium (typical values
200 to 300 ms).
All measurements were performed by fully
blinded operators at the CMR core laboratory,
which has proven excellent reproducibility for in-
farct size (22), myocardial salvage, and microvascu-
lar obstruction assessment (14). Infarct size and
AAR by T2 edema were assessed by manual pla-
imetry and expressed as percentage of LV mass
14,22,23). A central core of hypointense signal
ithin the area of increased signal intensity,
hich is deemed to be intramyocardial hemor-
hage (24), was included in the AAR assessment.
are was taken to exclude increased signal inten-
ity from the blood pool adjacent to the endocar-
ium due to slow flow. AAR by ESA was
easured using ImageJ version 1.43u (National
nstitutes of Health, Bethesda, Maryland) as
reviously described (Fig. 3B) (8).
The following calculations were applied:
AAR assessed by T2-weighted CMR  volume
edema/volume LV mass  100
AAR assessed by ESA  summed endocardial
infarct length/total LV endocardial length  100
%infarct size  volume infarct/volume LV mass 
100
myocardial salvage  area at risk  infarct size
myocardial salvage index (area at risk infarct
size)/area at risk  100
Statistical analysis. Categorical data are presented as
counts or proportions with the corresponding per-
centages. All quantitative data are expressed as
mean  SD or median and interquartile range
(IQR) on the basis of whether they had a normaldistribution or not. Bland-Altman analyses were
applied to compare the 3 AAR measurement meth-
ods. Correlation analyses were done by Pearson or
Spearman tests, as indicated. Given the paired
nature of the data, a repeated-measures analysis of
variance with post hoc analysis and the use of the
Bonferroni correction to account for multiple test-
ing was used to detect differences among angio-
STEMI Patients (n = 251)
No CMR (31)
  Claustrophobia (n = 11)
  Death (n = 10)
  Obesity (n = 3)
  Refusal (n = 2)
  Dyspnea (n = 2)
  Pacemaker (n = 1)
  Metallic implant (n = 1)
  Others (n = 1)
No APPROACH-score (n = 23)
  No APPROACH-score for lesion (n = 20
  Technical Reasons (n = 3)
CMR studies (n = 220)
Angiographic and CMR analysis (n = 197)
Figure 1. Study Flow
APPROACH-score  Alberta Provincial Project for Outcome Assessm
Coronary Heart Disease Score; CMR  cardiac magnetic resonance;
ST-segment elevation myocardial infarction.
Table 1. Modiﬁed Angiographic APPROACH-Score
Culprit Lesion Location
Infarct-Related
Artery Side Branches
Diagonal for L
or Posterolate
Small or Absen
LAD Distal 13.75
Mid 27.5
Proximal 41.25
Proximal LCx (RD) Small or absent 9.25
Medium 15.25
Large 21.25
Proximal LCx (LD) Small or absent 23.5
Medium 29.5
Large 35.5
Mid LCx (LD) or RCA (RD) Small or absent 9.25
Medium 15.25
Large 21.25
Mid LCx (RD) 3.25
Results provided as percentage of left ventricular myocardium. Modiﬁed from
APPROACH-score  Alberta Provincial Project for Outcome Assessment in C
Score; LAD  left anterior descending artery; LCx  left circumﬂex artery; LD )
ent in
STEMI AD Occlusion Only
ral for All Others
t Medium Large
14.8 15.9
29.7 31.8
44.5 47.75
12.5 15.75
18.5 21.75
24.5 27.75
28 32.5
34 38.5
40 44.5
12.5 15.75
18.5 21.75
24.5 27.75
6.5 9.75
Ortiz-Perez et al. (8).
oronary Heart Disease
left dominant; RCA right coronary artery; RD  right dominant.
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970graphic AAR, ESA, and T2-weighted imaging. A
trend analysis using analysis of variance was used to
analyze a possible influence of myocardial salvage
index (MSI) on AAR assessment with the 3
methods.
Statistical analysis was performed using commer-
cially available software (SPSS 17.0, SPSS Inc.,
Chicago, Illinois). A 2-tailed p value 0.05 was
considered statistically significant.
RE SULTS
Of 251 eligible STEMI patients, this study in-
cluded 197 patients. The main reasons for exclusion
from the study are listed in Figure 1. Demographic
and clinical characteristics are shown in Table 2.
he culprit vessel was the left anterior descending
oronary artery in 87 (44.2%) patients, the left
ircumflex coronary artery in 12 (6.1%), and the
ight coronary artery in 98 (49.7%) patients. Time
rom symptom onset to angioplasty ranged from 45
o 720 min (median: 231 [IQR: 153 to 290]). The
edian time between reperfusion and CMR was 3
ays (IQR: 2 to 4).
Comparison of AAR assessed by T2-weighted imaging
with LGE infarct size. All patients had a region of
increased transmural signal intensity on T2-
eighted images in the territory of the corre-
ponding culprit artery (Figs. 2 and 3). The
2-weighted AAR (35.6  10.9 %LV) was
ignificantly larger than infarct size (18.2  11.7
LV; p  0.001). In total, 11 patients had
egional edema, but no LGE consistent with an
Figure 2. Coronary Angiogram With Culprit Lesion and Corresp
(A) Coronary angiogram with culprit lesion and corresponding edem
patient with occluded proximal left anterior descending coronary a
score of 44.5 %LV area at risk (AAR). (B) Corresponding T2-weighted
the interventricular septum (AAR: 49.0 %LV). %LV  percentage ofborted infarction (25) and 19 patients had evi- Aence of prior infarction (with LGE in a different
ascular territory).
The calculated myocardial salvage was 17.5 
1.6 %LV and the myocardial salvage index 49.3 
7.3.
Comparison of AAR assessed by T2-edema versus
APPROACH-score. AAR assessed with T2-weighted
imaging showed good correlation with the angio-
graphic AAR (r  0.87; p  0.001). However, as
shown by Bland-Altman analyses (Fig. 4A) there
was a certain bias toward an overestimation of the
AAR by T2-weighted CMR in comparison to
ngiographic scoring (35.6  10.9 %LV vs. 27.9 
0.5 %LV, difference: 7.7  5.4; p  0.001) with
imits of agreement of 10.6 %LV.
Comparison of AAR assessed by T2-edema versus ESA.
AAR by ESA showed only a moderate correlation
with the AAR determined by T2-weighted imaging
r  0.56; p  0.001). Furthermore, a significant
ifference between these 2 approaches (35.7  10.9
LV vs. 20.0  11.7 %LV, difference 15.7  10.7;
 0.001) with limits of agreement of 21.4 %LV
as evident (Fig. 4B).
Comparison of AAR assessed by ESA versus APPROACH-
score. There was only moderate correlation be-
tween ESA and angiographic scoring (r  0.44; p
0.001). Consequently, the AAR was signifi-
antly different between these 2 approaches (20.0
11.7 %LV vs. 27.9  10.5 %LV, difference: 8.0
11.8; p  0.001) with higher values of the
AR using the APPROACH-score. The limits
f agreement were 23.1 %LV in our Bland-
ing Edema in CMR
n cardiac magnetic resonance (CMR). Coronary angiogram of a
(arrow) and medium side branches resulting in an APPROACH-
R study showing edema (arrows) in the anterior wall and parts of
ventricular mass.ond
a i
rtery
CMltman analysis (Fig. 4C).
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971Inﬂuence of MSI on AAR measurement. The extent of
he AAR assessed by T2-weighted CMR and the
PPROACH-score was independent from the
mount of MSI (mean 49.3  27.3). Thus, no
ignificant correlation between T2-weighted imag-
ing as well as the APPROACH-score with the
MSI could be observed (r  0.21, p  0.77; r 
0.08, p  0.26, respectively). In contrast, the ESA
showed a significant negative correlation to the
MSI (r0.61; p 0.001). When categorized by
quartiles of MSI, patients with a large MSI had a
significantly smaller AAR as assessed by the ESA
method, in comparison to T2-weighted imaging
and the APPROACH-score (Fig. 5).
Correlation of infarct size on AAR measurement. Only
weak correlation was seen between infarct size and
2-weighted imaging (r  0.48; p  0.001) or
PPROACH-score (r  0.34; p  0.001),
hereas there was a strong correlation of ESA to
nfarct size (r  0.81; p  0.001). This was also
bserved when the infarct size was categorized in
uartiles (Fig. 6).
D I SCUS S ION
This is the largest study to date to compare and
validate the assessment of myocardium at risk with
2 different CMR methods in a large cohort of
consecutive STEMI patients. We could show that
AAR assessment with T2-weighted CMR corre-
lates well with angiographic scoring by the
APPROACH-score, whereas AAR by ESA seems
to be dependent on MSI and may not reflect the
true AAR.
AAR assessment in AMI. The reliable assessment of
he AAR in relation to infarct size enables deter-
ination of myocardial salvage and, consequently,
f efficacy of reperfusion therapy in patients with
TEMI. This is important for the evaluation of
ew therapeutic approaches in both interventional
nd pharmacological strategies for improvement of
eperfusion success and reduction of reperfusion
njury.
In the current study, we were able to show that
here is excellent correlation between the AAR
easured by T2-weighted imaging and the an-
giographic APPROACH-score, which is an an-
atomically and prognostically validated measure
of the extent of myocardial jeopardy. This is in
line with a recently published study of 50 AMI
patients, which also found that AAR estimated
by T2-weighted CMR was a predictor of the
PPROACH-score (17). In contrast, AAR de- wermination by ESA in our study showed only a
oderate correlation to both T2-weighted and
he angiographic AAR. The main reason for
hese differences might be that the ESA method
ignificantly underestimates the AAR in patients
Figure 3. AAR by CMR
(A) Inferior acute myocardial infarction (AMI) with resulting inferior
and late gadolinium enhancement (LGE) (upper panels) as well as
sponding edema and infarct size contours (green, lower panels). In
patient, there was only minimal myocardial salvage. (B) Anterosept
with corresponding edema (upper left panel) and infarct size (upp
panel) assessed by CMR in a patient with high myocardial salvage
(MSI) showing a large difference of the AAR assessed with T2-weigh
edema imaging (green, lower left panel) versus the endocardial su
area (ESA) (green, lower right panel). Abbreviations as in Figures 1edema
corre-
this
al AMI
er right
index
ted
rfaceith major myocardial salvage. Ubachs et al. (16)
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972could similarly demonstrate in a small study
cohort that the ESA is not suitable for AAR
assessment in patients with early reperfusion as
well as aborted infarction.
The characteristic CMR pattern of an aborted
infarction is the detection of myocardium at risk
in the absence of LGE (25). In these patients, the
ESA allows no reliable assessment of the AAR, as
the ESA method would generate an AAR of 0%,
whereas the true salvaged AAR is 100%. Eleven
patients in the present study showed no signs of
infarction by LGE but did, however, show evi-
dence of ischemic myocardium by T2-weighted
imaging. Consequently, LGE or ESA imaging
does not allow for determination of AAR in
aborted infarction, whereas T2-weighted imaging
oes.
A recent study by Wright et al. (10) observed a
etter correlation between ESA and T2-weighted
Table 2. Patient Characteristics
Characteristics Patients (n  197)
Age, yrs 65.4 12.4
Male sex 136 (69)
Body mass index, kg/m2 27.5 4.0
Cardiovascular risk factors
Current smoking 74 (38)
Hypertension 138 (70)
Hypercholesterolemia 62 (32)
Diabetes mellitus 49 (25)
Prior myocardial infarction 19 (10)
Prior coronary artery bypass grafting 3 (2)
Localization of myocardial infarction
Anterior 87 (44)
Posterior 98 (50)
Lateral 12 (6)
Killip class on admission
1 145 (74)
2 43 (22)
3 7 (3)
4 2 (1)
Concomitant medications
Beta-blockers 196 (99.5)
ACE-inhibitors/angiotensin-1 antagonist 197 (100)
Aspirin 197 (100)
Clopidogrel 197 (100)
Statins 197 (100)
Aldosterone-antagonist 8 (4)
Glycoprotein IIb/IIIa inhibitor 187 (95)
Door-to-balloon time, min 26 (21–35)
Pain-to-balloon time, min 231 (153–290)
Values are mean  SD, n (%), or median (IQR).
ACE  angiotensin-converting enzyme; IQR  interquartile range.maging than our study did (r  0.77). However, inur study, a significant portion of patients was
reated within 2 h following symptom onset with
onsequently a high degree of myocardial salvage
28 patients), whereas in the study by Wright et al.
10) the shortest pain-to-balloon time was 120 min.
ecent publications found the highest MSI in AMI
eperfused the first 2 h after onset of symptoms
15,26).
We and others found only moderate correlation
etween angiographic risk scores and infarct ESA,
n contrast to the results reported by Ortiz-Perez et
l. (8). This might be due in part to different study
opulations, because Ortiz-Perez et al. (8) only
tudied patients with TIMI (Thrombolysis In
yocardial Infarction) flow grade 0 before inter-
ention and patients with a pain-to-balloon times
60 min, indicating a lack of patients with high
SI.
Similar to a previous study (17), we found a
ystematic overestimation of T2-weighted AAR in
elation to angiographic AAR by the APPROACH-
core. This might be explained by a significant
ncrease of myocardial thickness in the infarcted
egion, which has been shown in experimental
27,28), patient (29), and imaging studies (30), as
ompared to noninfarcted areas. The APPROACH-
core (3), however, is based on older autopsy studies
19,20,31) and was created to obtain prognostic
nformation for overall coronary heart disease and is
ot exclusively dedicated to AMI patients. Thus,
he APPROACH-score does not account for such
n ischemia-related increased wall thickness. Nota-
ly, early postmortem analysis with microspheres
n an animal model (6) and comparison to SPECT
n humans (13) showed no significant differences in
omparison to the T2-weighted CMR–detected
AR.
Although it is possible to image the AAR with
PECT, determination of the AAR and myocar-
ial salvage in routine clinical practice by SPECT
s impractical and limited to specialized centers.
ajor limitations of SPECT include the need of
he perfusion tracer injection before reperfusion,
maging with a gamma camera within a few
ours, the need of 2 SPECT scans with radiation
xposure. In contrast, CMR allows AAR delin-
ation as well as estimation of the salvaged
yocardium retrospectively in 1 scan after the
cute event. Notably, the AAR by T2-weighted
imaging does not change during the first week
after infarction, enabling myocardial salvage as-
sessment after stabilization of the AMI patient
(13). Additionally, CMR provides important in-
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973formation about ventricular anatomy, function,
and microvascular status (32).
Study limitations. Some patients had to be ex-
cluded because of missing angiographic scoring
for side branch lesions or codominant coronary
anatomy. In addition, we did not assess several
clinical variables such as the collateral blood flow
or preconditioning, which might affect myocar-
dial salvage. Several limitations of T2-weighted
edema imaging have to be mentioned such as
signal intensity variability caused by phased-array
coils (although we used a body coil in the data
A
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)
A
Edema (%LV)
r = 0.87
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r = 0.56
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r = 0.44
0
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Figure 4. Comparison of the Different AAR Assessment Method
Correlation (left column) and Bland-Altman analysis (right colum
T2-weighted AAR (B), as well as ESA and angiographic scoring (A
ﬁt, dotted lines indicate an ideal correlation. In the Bland-Altma
ference or bias, and upper and lower dotted lines represent the
and 3.acquisition of the present analysis), high signal afrom slow moving ventricular chamber blood that
can mimic and mask elevated T2 in subendocar-
dial myocardium, motion artifacts, and also the
partly subjective nature of T2-weighted image
nterpretation. Technical developments such as
2-mapping may provide an even more robust
nd qualitative approach to edema imaging (33).
n our study, we also performed quantitative
nalysis by manual drawing of the edema border
ontours, which might be inferior to a semiauto-
atic analysis. However, we have previously
hown an excellent intra- and interobserver vari-
Mean Edema and APPROACH (%LV)
7.7 ± 5.4 %LV
20
0
20
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0 20 40 6010 30 50 70
Mean Edema and ESA (%LV)
15.7 ± 10.7 %LV
-20
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974edema imaging and LGE measurements with
manual planimetry (14,22), minimizing an influ-
ence on the data.
CONCLUS IONS
In conclusion, CMR can provide information on
myocardium at risk and salvaged myocardium using
T2-weighted edema imaging, with a good correlation
o the angiographic APPROACH-score. AAR deter-
T2 Edema
36.9 ± 9.7 
35.2 ± 11.9
35.1 ± 10.6
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         MSI
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Figure 5. Impact of MSI on AAR Assessed by Different Measure
Note a signiﬁcant difference in AAR assessed by ESA with different
Group 2: 25% to 50% MSI; Group 3: 50% to 75% MSI; Group 4:
 T2 Edema
  31.5 ± 10.6 
 33.3 ± 11.9
33.4 ± 6.9
44.6 ± 8.6
  Infarct Size
Quartile 1
Quartile 2
Quartile 3
Quartile 4
pp for trend <0.001
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Figure 6. Mean AAR for Quartiles of Infarct Size
Mean AAR for quartiles of infarct size (mean infarct size: Quartile 1:
%LV; Quartile 4: 34.0  6.3 %LV). Although all methods showed sig
with higher AAR, a strong dependence of AAR to infarct size could onlyination by ESA seems to depend on myocardial
alvage and underestimates the AAR, especially in
atients with high myocardial salvage and, therefore,
annot be recommended for AAR assessment.
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ts
ls of MSI. (MSI was divided in 4 groups: Group 1: 0% to 25% MSI;
% to 100% MSI). Abbreviations as in Figures 1, 2, and 3.
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